Protease inhibitors

Details for Australian Patent Application No. 2007337830 (hide)

Owner Ambrilia Biopharma Inc.

Inventors Leberre, Nicolas; Milot, Guy; Lavallee, Jean-Francois; Panchal, Chandra J.; Stranix, Brent Richard; Herbart, Dominik; Perron, Valerie

Agent Peter Maxwell & Associates

Pub. Number AU-A-2007337830

PCT Pub. Number WO2008/078200

Priority 60/846,084 21.09.06 US

Filing date 20 September 2007

Wipo publication date 3 July 2008

International Classifications

C07C 311/41 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/078200 Priority application(s): WO2008/078200

21 May 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Ambrilia Biopharma Inc., Application No. 2007337830, under INID (54) correct the title to read Benzenesulfonamide derivatives as HIV protease inhibitors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007337831-Printing apparatus

2007337826-Substituted heteroaryl pyridopyrimidone derivatives